封面
市場調查報告書
商品編碼
1750791

動物CRO/CDMO市場規模、佔有率、趨勢分析報告:按動物、服務、應用、地區、細分市場預測,2025-2030年

Veterinary CRO And CDMO Market Size, Share & Trends Analysis Report By Animal (Companion Animals, Livestock Animals), By Service (Discovery, Development), By Application (Medicine, Medical Devices), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

動物 CRO/CDMO 市場的成長與趨勢:

根據 Grand View Research, Inc. 的新報告,全球獸醫 CRO/CDMO 市場規模預計到 2030 年將達到 114.2 億美元,2025 年至 2030 年的複合年成長率為 9.2%。

預計動物保健支出的增加、研發等外包流程的日益成長趨勢以及全球對有效動物用藥品解決方案的需求的不斷成長將推動市場成長。

對開發安全有效的疫苗以預防農場動物致命疾病的巨額投資、對伴侶動物新型藥物日益成長的需求以及寵物主人數量的增加都在影響著這個市場。此外,CRO 提供的技術力、CDMO 的先進設施能力、改進的供應鏈管理和便利的分銷也促進了其成長。

動物用藥品製造商與合約研究組織 (CRO) 和合約研發生產組織 (CDMO) 之間在臨床試驗、研究、發現和開發等各種應用領域加強合作,有望創造豐厚的機會。預計主要市場參與企業在產品組合最佳化、產能擴張和製程改進方面的重大投資將在預測期內推動成長。

動物CRO/CDMO市場報告重點

  • 由於人們對肉類和其他與農場動物相關的產品的安全擔憂日益加劇、新型疾病頻繁爆發以及對有效疫苗的需求不斷增加,農場動物部門在 2024 年佔據了收益佔有率%。
  • 由於各種動物保健產品(包括專為寵物設計的藥品和設備)的使用量大幅增加,預計伴侶動物領域將快速成長。
  • 由於多家動物用藥品公司更加重視開發與動物保健和營養相關的創新產品,開發部門在 2024 年佔據了市場的最大收益佔有率。
  • 2025年至2030年間,由於對動物用藥品研究活動的投資不斷增加,探勘產業預計將成長最快。
  • 根據應用,製藥業在 2024 年佔據最高的市場收益佔有率。
  • 憑藉強大的製藥和生物技術產業、多家 CRO/CDMO 的存在以及不斷增加的動物用藥品支出,北美在 2024 年佔據了全球產業的主導地位。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章。全球動物 CRO/CDMO 市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球動物CRO/CDMO市場分析工具
    • 產業分析—波特五力分析
    • PESTLE分析

第4章 全球動物CRO/CDMO市場:動物業務分析

  • 動物細分儀表板
  • 動物CRO/CDMO市場:動物波動分析
  • 全球動物 CRO/CDMO 市場規模及趨勢分析(按動物,2018-2030 年)
  • 伴侶動物
  • 家畜

第5章全球動物CRO/CDMO市場:服務業務分析

  • 服務細分儀表板
  • 動物CRO/CDMO市場:服務波動分析
  • 全球動物 CRO/CDMO 市場規模及趨勢分析(按服務,2018-2030 年)
  • 發現
  • 發展
  • 製造業
  • 包裝和標籤
  • 市場核准和上市後監督

6. 全球動物CRO/CDMO市場:應用業務分析

  • 應用程式細分儀表板
  • 動物CRO/CDMO市場:應用趨勢分析
  • 全球動物 CRO/CDMO 市場規模及趨勢分析(按應用,2018-2030 年)
  • 製藥
  • 醫療設備

第7章全球動物CRO/CDMO市場:區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 全球動物 CRO/CDMO 市場(按地區)關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 哥倫比亞
    • 阿根廷
    • 智利
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Fortrea
    • Charles River Laboratories
    • Clinvet(Clinglobal)
    • KLIFOVET GmbH(Argenta Group)
    • OCRvet(Clinglobal)
    • Knoell-Triveritas
    • Veterinary Research Management
    • VETSPIN SRL
    • Inotiv
    • IDEXX
    • Vetio
    • TriRx Pharmaceutical Services
Product Code: GVR-4-68040-053-0

Veterinary CRO And CDMO Market Growth & Trends:

The global veterinary CRO and CDMO market size is anticipated to reach USD 11.42 billion by 2030 and is anticipated to expand at a CAGR of 9.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing expenditure on animal healthcare, growing inclination toward outsourcing processes such as research and development, and rising demand for effective animal health solutions worldwide are expected to drive market growth.

Significant investments in developing safe and efficient vaccines to prevent life-threatening diseases in livestock animals, growth in demand for novel medicines designed for companion animals, and an increase in pet ownership influence this market. In addition, the technical competence offered by CROs, advanced equipment capabilities of CDMOs, improved supply chain management, and easy distribution contribute to growth.

Rising collaborations among animal health companies and CROs or CDMOs for various applications, including clinical trials, research, discovery, and development, are likely to develop lucrative opportunities. Noteworthy investments by key market participants in portfolio enhancement, capacity expansion, and improved processes are projected to aid growth over the forecast period.

Veterinary CRO And CDMO Market Report Highlights:

  • Livestock animals segment dominated the global market with more than 55% of revenue share in 2024 owing to growing concerns regarding the safety of meat and other byproducts associated with livestock animals, frequent outbreaks of novel diseases, and increasing demand for effective vaccines
  • The companion animals segment is expected to experience the fastest growth due to the significant increase in the adoption of various animal health products, such as medicine and devices specifically designed for pets
  • The development segment held the largest revenue share of the market in 2024, owing to the rising focus of multiple animal health companies on developing innovative products related to animal health and nutrition.
  • The discovery segment is expected to experience the fastest growth from 2025 to 2030, owing to increasing investment in research activities related to animal health products
  • In terms of application segment, medicine segment accounted for the highest market revenue share in 2024
  • North America dominated the global industry in 2024, owing to its strong pharmaceutical and biotechnology industry, presence of multiple CROs and CDMOs, and growing expenditures on animal health

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Animal
    • 1.2.2. Service
    • 1.2.3. Application
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Animal Outlook
    • 2.2.2. Service Outlook
    • 2.2.3. Application Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Veterinary CRO and CDMO Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Veterinary CRO and CDMO Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Global Veterinary CRO and CDMO Market: Animal Business Analysis

  • 4.1. Animal Segment Dashboard
  • 4.2. Veterinary CRO and CDMO Market: Animal Movement Analysis
  • 4.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Animal, 2018 to 2030 (USD Million)
  • 4.4. Companion Animals
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Livestock Animals
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Veterinary CRO and CDMO Market: Service Business Analysis

  • 5.1. Service Segment Dashboard
  • 5.2. Veterinary CRO and CDMO Market: Service Movement Analysis
  • 5.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Service, 2018 to 2030 (USD Million)
  • 5.4. Discovery
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Development
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Early Phase/Preclinical
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Late phase/Clinical
      • 5.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Manufacturing
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Packaging & Labeling
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Market Approval & Post Marketing
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Veterinary CRO and CDMO Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Veterinary CRO and CDMO Market: Application Movement Analysis
  • 6.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 6.4. Medicine
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Pharmaceuticals
      • 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Biologics
      • 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Medical Devices
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Veterinary CRO and CDMO Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Veterinary CRO and CDMO Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Italy
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.9.3. Competitive Scenario
      • 7.5.9.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Colombia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Chile
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Fortrea
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Charles River Laboratories
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Clinvet (Clinglobal)
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. KLIFOVET GmbH (Argenta Group)
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. OCRvet (Clinglobal)
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Knoell - Triveritas
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Veterinary Research Management
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. VETSPIN SRL
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Inotiv
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. IDEXX
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Vetio
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. TriRx Pharmaceutical Services
      • 8.4.12.1. Company Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Abbreviations
  • Table 2. Global Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 3. Global Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 4. Global Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 5. Global Veterinary CRO and CDMO Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 8. North America Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 9. North America Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 10. U.S. Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 11. U.S Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 12. U.S. Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 13. Canada Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 14. Canada Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 15. Canada Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 16. Mexico Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 17. Mexico Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 18. Mexico Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 19. Europe Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 20. Europe Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 21. Europe Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 22. Europe Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 23. Germany Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 24. Germany Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 25. Germany Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 26. UK Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 27. UK Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 28. UK Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 29. France Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 30. France Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 31. France Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 32. Italy Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 33. Italy Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 34. Italy Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 35. Spain Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 36. Spain Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 37. Spain Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 38. Denmark Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 39. Denmark Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 40. Denmark Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 41. Sweden Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 42. Sweden Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 43. Sweden Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 44. Norway Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 45. Norway Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 46. Norway Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 51. China Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 52. China Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 53. China Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 54. Japan Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 55. Japan Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 56. Japan Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 57. India Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 58. India Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 59. India Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 60. Australia Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 61. Australia Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 62. Australia Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 63. South Korea Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 64. South Korea Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 65. South Korea Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 66. Thailand Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 67. Thailand Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 68. Thailand Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 69. Latin America Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 70. Latin America Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 71. Latin America Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 72. Latin America Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 73. Brazil Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 74. Brazil Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 75. Brazil Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 76. Columbia Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 77. Columbia Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 78. Columbia Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 79. Argentina Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 80. Argentina Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 81. Argentina Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 82. Chile Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 83. Chile Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 84. Chile Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 85. MEA Veterinary CRO and CDMO Market, By Region, 2018 - 2030 (USD Million)
  • Table 86. MEA Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 87. MEA Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 88. MEA Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 89. South Africa Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 90. South Africa Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 91. South Africa Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 92. Saudi Arabia Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 93. Saudi Arabia Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 94. Saudi Arabia Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 95. UAE Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 96. UAE Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 97. UAE Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 98. Kuwait Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 99. Kuwait Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Veterinary CRO and CDMO Market: Market Outlook
  • Fig. 10 Veterinary CRO and CDMO Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Veterinary CRO and CDMO Market Driver Impact
  • Fig. 16 Veterinary CRO and CDMO Market Restraint Impact
  • Fig. 17 Veterinary CRO and CDMO Market Strategic Initiatives Analysis
  • Fig. 18 Veterinary CRO and CDMO Market: Animal Movement Analysis
  • Fig. 19 Veterinary CRO and CDMO Market: Animal Outlook and Key Takeaways
  • Fig. 20 Companion Animal Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Livestock Animal Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Veterinary CRO and CDMO Market: Service Movement Analysis
  • Fig. 23 Veterinary CRO and CDMO Market: Service Outlook and Key Takeaway
  • Fig. 24 Discovery Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Development Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Early Phase/Preclinical Development Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Late phase/Clinical Development Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Manufacturing Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Packaging & Labeling Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 Market Approval & Post Marketing Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 Veterinary CRO and CDMO Market: Application Movement Analysis
  • Fig. 32 Veterinary CRO and CDMO Market: Application Outlook and Key Takeaways
  • Fig. 33 Medicine Market Estimates and Forecast, 2018 - 2030
  • Fig. 34 Pharmaceuticals Market Estimates and Forecast, 2018 - 2030
  • Fig. 35 Biologics Market Estimates and Forecast, 2018 - 2030
  • Fig. 36 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 37 Medical Devices Market Estimates and Forecast, 2018 - 2030
  • Fig. 38 Global Veterinary CRO and CDMO Market: Regional Movement Analysis
  • Fig. 39 Global Veterinary CRO and CDMO Market: Regional Outlook and Key Takeaways
  • Fig. 40 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Denmark Market Estimates and Forecasts, 2018-203
  • Fig. 51 Sweden Market Estimates and Forecasts, 2018-203
  • Fig. 52 Norway Market Estimates and Forecasts, 2018-203
  • Fig. 53 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Columbia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Chile Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 Kuwait Market Estimates and Forecasts, 2018 - 2030